Piper Sandler analyst Arvind Ramnani upgraded Accenture to Overweight from Neutral with a price target of $395, up from $329. While overall FY25 guidance was in-line with the firm’s expectations, Piper is “bullish on the underlying metrics,” including “robust bookings” and a significant step up in hiring, the analyst tells investors. Given that full-year guidance assumes no improvement beyond Q1, and that the company is starting to see some scaled GenAI projects, the setup for FY25 “seems attractive” and the firm believes owning the stock is attractive given improving top-line metrics, what it views as “conservative” guidance and the fact that the company is a key beneficiary of GenAI related work.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACN:
- Accenture upgraded to Outperform from Neutral at Piper Sandler
- Micron reports Q4 beat, Pfizer withdraws Oxbryta: Morning Buzz
- Unusually active option classes on open September 26th
- Morning Movers: Micron and Accenture rise following quarterly results
- Options Volatility and Implied Earnings Moves Today, September 26, 2024